SomnoMed (ASX:SOM) Total Equity : A$29.90 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Total Equity?

SomnoMed's total equity for the quarter that ended in Dec. 2023 was A$29.90 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SomnoMed Total Equity Historical Data

The historical data trend for SomnoMed's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Total Equity Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Equity

Get a 7-Day Free Trial

17.82

33.84

32.16

27.79

22.40

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Equity	Get a 7-Day Free Trial															29.04	27.79	25.02	22.40	29.90

SomnoMed Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SomnoMed's Total Equity for the fiscal year that ended in Jun. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2023 )	-	Total Liabilities(Q: Jun. 2023 )
	=	62.491	-	40.088
	=	22.40

SomnoMed's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	63.917	-	34.016
	=	29.90

SomnoMed Total Equity Related Terms

Thank you for viewing the detailed overview of SomnoMed's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines